{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:05:17Z","timestamp":1789243517090,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1402222"],"award-info":[{"award-number":["U1402222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejmech.2017.07.040","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T20:46:05Z","timestamp":1500756365000},"page":"1114-1125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents"],"prefix":"10.1016","volume":"138","author":[{"given":"Yuanyuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.07.040_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0955-0674(98)80082-3","article-title":"Tubulin and microtubule structure","volume":"10","author":"Downing","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejmech.2017.07.040_bib2","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance","volume":"8","author":"Perez","year":"2009","journal-title":"Mol. cancer Ther."},{"key":"10.1016\/j.ejmech.2017.07.040_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics, Nature reviews","volume":"9","author":"Dumontet","year":"2010","journal-title":"Drug Discov."},{"key":"10.1016\/j.ejmech.2017.07.040_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ejmech.2014.08.005","article-title":"Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studies","volume":"85","author":"Sharma","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1081\/CNV-200055970","article-title":"Review: tubulin function, action of antitubulin drugs, and new drug development","volume":"23","author":"Pellegrini","year":"2005","journal-title":"Cancer Investig."},{"key":"10.1016\/j.ejmech.2017.07.040_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2014.09.053","article-title":"Design and synthesis of pironetin analogue\/combretastatin A-4 hybrids containing a 1,2,3-triazole ring and evaluation of their cytotoxic activity","volume":"87","author":"Vilanova","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2013.10.077","article-title":"Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents","volume":"92","author":"Kamal","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/febs.13555","article-title":"Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery","volume":"283","author":"Wang","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2017.07.040_bib9","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1073\/pnas.1408124111","article-title":"A\u00a0new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs","volume":"111","author":"Prota","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.07.040_bib10","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.1021\/bi010869+","article-title":"The interaction of baccatin III with the taxol binding site of microtubules determined by a homogeneous assay with fluorescent taxoid","volume":"40","author":"Andreu","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2017.07.040_bib11","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1074\/jbc.271.25.14707","article-title":"Localization of the vinblastine-binding site on b-tubulin","volume":"271","author":"Rai","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib12","article-title":"Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents","volume":"4","author":"Haar","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"issue":"Suppl 5","key":"10.1016\/j.ejmech.2017.07.040_bib14","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1093\/annonc\/mdm172","article-title":"Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents","volume":"18","author":"Fojo","year":"2007","journal-title":"Ann. Oncol. official J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.ejmech.2017.07.040_bib15","doi-asserted-by":"crossref","DOI":"10.1021\/cr9000226","article-title":"ABC efflux pump-based resistance to chemotherapy drugs","volume":"109","author":"Eckford","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2017.07.040_bib16","first-page":"680","volume":"vol. 45","author":"Pettit","year":"1988"},{"key":"10.1016\/j.ejmech.2017.07.040_bib17","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/annonc\/mdq708","article-title":"Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer","volume":"22","author":"Zweifel","year":"2011","journal-title":"Ann. Oncol. official J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.ejmech.2017.07.040_bib18","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.bjc.6605650","article-title":"A\u00a0Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer","volume":"102","author":"Rustin","year":"2010","journal-title":"Br. J. cancer"},{"key":"10.1016\/j.ejmech.2017.07.040_bib19","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/acs.jmedchem.6b00158","article-title":"Design, synthesis, and evaluation of in\u00a0vitro and in\u00a0vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/0929867003373283","article-title":"DNA minor groove alkylating agents","volume":"8","author":"Denny","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib21","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/0008-5472.CAN-03-2868","article-title":"Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase","volume":"64","author":"Rabindran","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2017.07.040_bib22","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1158\/1078-0432.CCR-11-0411","article-title":"Biologic and clinical activity of tivozanib (AV-951, KRN-951), a selective inhibitor of VEGF receptor-1, -2, and -3 tyrosine kinases, in a 4-week-on, 2-week-off schedule in patients with advanced solid tumors","volume":"17","author":"Eskens","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2017.07.040_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmech.2016.02.069","article-title":"Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors","volume":"114","author":"Shobeiri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ejmech.2016.11.012","article-title":"Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors","volume":"127","author":"Khelifi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib25","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1016\/j.ejmech.2011.05.020","article-title":"Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization","volume":"46","author":"Coluccia","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejmech.2016.12.043","article-title":"Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors","volume":"127","author":"Sri Ramya","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1124\/dmd.107.016998","article-title":"In\u00a0vitro metabolism study of combretastatin A-4 in rat and human liver microsomes","volume":"35","author":"Aprile","year":"2007","journal-title":"Drug metabolism Dispos. Biol. fate Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000068411","article-title":"Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-Glycoprotein expression","volume":"70","author":"Yeh","year":"2003","journal-title":"Respiration"},{"key":"10.1016\/j.ejmech.2017.07.040_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.07.040_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","article-title":"Multiple drug resistance mechanisms in cancer","volume":"46","author":"Baguley","year":"2010","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ejmech.2017.07.040_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2017.07.040_bib32","first-page":"164","article-title":"New insights into mechanisms of resistance to microtubule inhibitors","volume":"1816","author":"Ganguly","year":"2011","journal-title":"Biochimica biophysica acta"},{"key":"10.1016\/j.ejmech.2017.07.040_bib33","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1021\/jm500849z","article-title":"Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors","volume":"57","author":"Yang","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000445640","article-title":"Verteporfin can reverse the paclitaxel resistance induced by YAP over-expression in HCT-8\/t cells without photoactivation through inhibiting YAP expression","volume":"39","author":"Pan","year":"2016","journal-title":"Cell. Physiology Biochem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00685929","article-title":"Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH","volume":"34","author":"Zacherl","year":"1994","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.07.040_bib36","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1248\/bpb.30.2279","article-title":"The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells","volume":"30","author":"Liu","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2017.07.040_bib37","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.bmcl.2009.04.070","article-title":"Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III \u03b2-tubulin","volume":"19","author":"Pepe","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.040_bib38","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1021\/acs.jmedchem.5b00910","article-title":"Scaffold diversity inspired by the Natural product evodiamine: discovery of highly potent and multitargeting antitumor agents","volume":"58","author":"Wang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib39","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejmech.2016.07.002","article-title":"Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents","volume":"122","author":"Yang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12575-010-9029-5","article-title":"Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site","volume":"12","author":"Fortin","year":"2010","journal-title":"Biol. Proced. online"},{"key":"10.1016\/j.ejmech.2017.07.040_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2013.01.007","article-title":"Synthesis and biological evaluation of novel pyranochalcone derivatives as a new class of microtubule stabilizing agents","volume":"62","author":"Cao","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ejmech.2012.06.034","article-title":"Design, synthesis, and structure-activity relationship studies of novel millepachine derivatives as potent antiproliferative agents","volume":"54","author":"Wang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib43","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1016\/j.bmc.2013.02.002","article-title":"Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors","volume":"21","author":"Wang","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib44","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.bmc.2014.02.028","article-title":"Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.040_bib45","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acs.jmedchem.5b01342","article-title":"Discovery of selective histone deacetylase 6 inhibitors using the quinazoline as the cap for the treatment of cancer","volume":"59","author":"Yang","year":"2016","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417305627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417305627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T21:25:40Z","timestamp":1535577940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417305627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":45,"alternative-id":["S0223523417305627"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.040","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}